
(VIBRANT) trial randomized 148 patients to PTFE
covered or nitinol BMSs for lesions averaging 18 cm in
length. At 3 years, primary patency was nearly identical
(24.2% vs 25.9%).196 Some authors have raised caution
about the failure mode of covered stents in FPOD, with
a higher proportion of acute limb ischemia events
compared with B